Company Zomedica Corp.

Equities

ZOM

CA98980M1095

Healthcare Facilities & Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Annual profits - Rate of surprise

Market Closed - Nyse Other stock markets 04:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
0.1564 ^USD	-0.06%		-4.92%	-21.88%

Jun. 04	Zomedica Completes Expansion of Manufacturing, Distribution Facilities in Roswell, Georgia	MT
May. 15	Zomedica Corp. Releases Over-The-Air Software Update Capabilities for Its Truforma(R) Platform	CI

Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic Devices segment consists of Assisi and PulseVet products. Its TRUFORMA platform comprises point-of-care diagnostic products for disease states in dogs, cats and horses, providing assays for use at the point-of-care that provide reference lab accuracy. Its TRUVIEW platform consists of the TRUVIEW digital cystoscopy instrument providing microscopic images and related pathology services which enable practitioners to receive a pathologist interpretation of the images. The Assisi Loop platform includes a series of products that use targeted pulsed electromagnetic field (tPEMF) therapy.

Number of employees: 144

USD in Million	2022	Weight	2023	Weight	Delta
Therapeutics 94.5 %	19	97.9 %	24	94.5 %	+28.43%
Diagnostics 5.5 %	0	2.1 %	1	5.5 %	+252.17%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	19	100.0 %	25	100.0 %	+33.05%

Managers	Title	Age	Since
Larry Heaton CEO	Chief Executive Officer	67	21-09-30
Peter Donato DFI	Director of Finance/CFO	54	23-03-15
Evan Saint Peter CTO	Chief Tech/Sci/R&D Officer	-	17-12-31
Ashley Wood CTO	Chief Tech/Sci/R&D Officer	-	18-12-31
Anthony Blair COO	Chief Operating Officer	63	21-12-31
Robert Cohen BRD	Director/Board Member	66	20-06-15
Karen DeHaan-Fullerton LAW	General Counsel	56	22-05-30
Kristin Domanski HRO	Human Resources Officer	-	22-01-01
Nicole Westfall SAM	Sales & Marketing	-	-
Greg Blair PRN	Corporate Officer/Principal	-	21-05-16

Members of the board	Title	Age	Since
Larry Heaton CEO	Chief Executive Officer	67	21-09-30
Johnny Powers BRD	Director/Board Member	62	19-08-15
Robert Cohen BRD	Director/Board Member	66	20-06-15
Sean Whelan BRD	Director/Board Member	53	21-09-12
Jeffrey Rowe CHM	Chairman	68	16-04-26
Rodney Williams BRD	Director/Board Member	63	16-04-26
Pamela Nichols BRD	Director/Board Member	61	22-08-22
Christopher MacLeod BRD	Director/Board Member	54	20-07-08

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	979,949,668	963,832,238 ( 98.36 %)	0	98.36 %

Name	Equities	%	Valuation
Vanguard Global Advisers LLC 4.932 %	48,326,991	4.932 %	6 M $
Jeffrey Rowe 1.249 %	12,240,480	1.249 %	2 M $
Geode Capital Management LLC 1.033 %	10,120,991	1.033 %	1 M $
BlackRock Institutional Trust Co. NA 1.006 %	9,862,981	1.006 %	1 M $
STATE STREET CORPORATION 0.3174 %	3,110,581	0.3174 %	404 376 $
Brown Brothers Harriman & Co. (Investment Management) 0.2517 %	2,466,532	0.2517 %	320 649 $
Johnny Powers 0.2271 %	2,225,000	0.2271 %	289 250 $
Northern Trust Investments, Inc.(Investment Management) 0.1835 %	1,798,385	0.1835 %	233 790 $
Atom Investors LP 0.1226 %	1,201,048	0.1226 %	156 136 $
Russell Kevin Klass 0.1021 %	1,000,050	0.1021 %	130 007 $

Zomedica Corp.

100 Phoenix Drive Suite 125

48108-2635, Ann Arbor

http://www.zomedica.com

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Veterinary Services

Company calendar